Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-047336

Chief Financial Officer sold 10,000 shares at $13.50 ($135,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-28 Option exercise +10,000 $2.88 $28,750 260,004 D
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-28 Sale −10,000 $13.50 $135,000 250,004 D
Derivatives
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-28 Option exercise · Stock Option (Right to Buy) −10,000 0 D
Open-market sales · 10,000 sh · avg $13.50 · $135,000
Loading xslF345X03/tv502084_4.xml…